Target intelligence / Profile preview

Copper ion homeostasis

Molecular classification
Other
01

Overview

Copper ion homeostasis refers to the tightly regulated biological process that maintains appropriate intracellular and systemic concentrations of copper ions. This is essential because while copper is a vital trace element required for the function of numerous enzymes involved in redox reactions, mitochondrial respiration, melanin synthesis, collagen cross-linking, antioxidant defense (via superoxide dismutase), and iron metabolism (via ceruloplasmin), both deficiency and excess are harmful. The process involves coordinated uptake by transporters such as SLC31A1/CTR1; distribution via chaperones; storage mainly in the liver; incorporation into cuproenzymes; and excretion primarily through bile. Disruption leads to diseases such as Menkes disease (defective ATP7A transporter) or Wilson's disease (defective ATP7B transporter). Recent research has also linked dysregulated copper homeostasis with cancer progression—where targeting these pathways may offer therapeutic opportunities—and with neurodegenerative conditions. However, "Copper ion homeostasis" itself is not a single molecular target but rather a physiological process involving multiple proteins and pathways[1][2][3][4].

Other names
Copper homeostasisIntracellular copper ion homeostasisCellular copper balance
02

Mechanism of action

Supplementation to restore deficient copper-dependent enzyme activity (copper histidinate); Delivery of copper to cuproenzymes and induction of cuproptosis in cancer cells (elesclomol)

03

Biological functions

Maintenance of cellular copper levelsRegulation of redox reactionsSupport of enzymatic activity (as a cofactor)Cell signalingCell death regulation (cuproptosis)Protein trafficking
04

Disease associations

Neurodegenerative disease (e.g., Menkes disease, Wilson’s disease, Alzheimer’s disease, Parkinson’s disease)CancerHematologic disorders (anemia, neutropenia)Liver diseasesObesity
05

Safety considerations

Risk of toxicity with excess supplementation leading to tissue injury or organ damageDeficiency can cause severe neurological and hematological symptoms
06

Interacting drugs

Copper histidinate

1 more in the full profile.

07

Biomarkers

Serum ceruloplasmin levelsHepatic copper content

Beyond the preview

Go deeper on Copper ion homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper ion homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call